Viking Global
Work Here?
About
Company Stage
N/A
Employees
51-200
Industries
Fintech, Financial Services
Total Funding
$16.7B
Headquarters
Greenwich, Connecticut
Founded
1999
Simplify's Take
What believers are saying
- Viking Global benefits from FDA's Breakthrough Device Designation for Magenta Medical's Elevate System.
- Their investment in Diagonal Therapeutics supports novel approaches in agonist antibody development.
- Viking Global's involvement in Antheia's funding positions them for biopharmaceutical manufacturing advancements.
What critics are saying
- Competition in the heart pump market may impact returns from Magenta Medical investment.
- Challenges in program selection could delay new biotech company launches with AbCellera.
- Diagonal Therapeutics' platform may fail to achieve clinical proof-of-concept, risking investment.
What makes Viking Global unique
- Viking Global Investors is actively investing in innovative biotech and medical technologies.
- Their collaboration with AbCellera and ArrowMark focuses on pioneering antibody drug programs.
- Viking Global's diverse portfolio includes investments in heart pumps, biopharmaceuticals, and digital payments.
Help us improve and share your feedback! Did you find this helpful?
Viking Global is Hiring for 0 Jobs on Simplify!
Find jobs on Simplify and start your career today
💡
We update Viking Global's jobs every 8 hours, so check again soon! Browse all jobs →